HRMY
$36.61
Revenue | $200.49Mn |
Net Profits | $39.78Mn |
Net Profit Margins | 19.84% |
Harmony Biosciences Holdings Inc’s revenue jumped 16.01% since last year same period to $200.49Mn in the Q2 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated 8.53% jump in its revenue since last 3-months.
Harmony Biosciences Holdings Inc’s net profit jumped 243.16% since last year same period to $39.78Mn in the Q2 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated -12.7% fall in its net profits since last 3-months.
Harmony Biosciences Holdings Inc’s net profit margin jumped 195.79% since last year same period to 19.84% in the Q2 2025. On a quarterly growth basis, Harmony Biosciences Holdings Inc has generated -19.56% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.81 |
EPS Estimate Current Year | 0.81 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at 0.81 - a 13.18% jump from last quarter’s estimates.
Harmony Biosciences Holdings Inc’s earning per share (EPS) estimates for the current year stand at 0.81.
Earning Per Share (EPS) | 0.92 |
Harmony Biosciences Holdings Inc’s earning per share (EPS) jumped 360% since last year same period to 0.92 in the Q2 2025. This indicates that the Harmony Biosciences Holdings Inc has generated 360% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-08-05 | 0.72 | 0.92 | 27.78% |
2025-05-06 | 0.91 | 0.78 | -14.79% |